Table 2.
Treatment | Hb (mg/ml) | P50 (mmHg) | pH | K+ (mmol/L) | Na+ (mmol/L) | ATPase (U/107 cells) | 2,3-DPG (g/L) | Free Hb (mg/ml) |
Control | 60.53±11.61 | 19.08±4.96 | 7.46±0.13 | 1.47±0.53 | 150.22±1.11 | 0.080±0.018 | 9.68±1.77 | 0.089±0.004 |
HT30 | 60.85±11.52 | 20.73±6.29 | 7.44±0.13 | 1.77±0.63 | 150.27±1.12 | 0.068±0.023 | 9.05±1.41 | 0.091±0.006 |
HT60 | 59.90±10.72 | 20.14±6.11 | 7.42±0.13 | 2.01±0.68 | 150.11±1.59 | 0.067±0.021 | 8.47±1.29 | 0.091±0.008 |
HT120 | 58.71±11.52 | 20.12±6.08 | 7.41±0.13 | 2.62±0.75** | 149.63±1.28 | 0.059±0.017 | 8.07±1.55 | 0.098±0.005** |
Data are expressed as mean±SD, with n=9 in each experiment
P<0.01 vs. control (treated at 37 °C for 30 min)
HT30, HT60, and HT120: hyperthermia for 30, 60, and 120 min, respectively